Biomarkers of Response to Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Chronic Lymphocytic Leukemia

被引：15

作者：

Fraietta, Joseph A. ^{[1
]}

Lacey, Simon F. ^{[1
]}

Wilcox, Nicholas S.

Bedoya, Felipe ^{[2
]}

Chen, Fang ^{[1
]}

Orlando, Elena ^{[3
]}

Brogdon, Jennifer L. ^{[3
]}

Hwang, Wei-Ting ^{[4
]}

Frey, Noelle ^{[1
]}

Young, Regina M. ^{[1
]}

Pequignot, Edward ^{[1
]}

Ambrose, David E. ^{[5
]}

Levine, Bruce L. ^{[1
]}

Bitter, Hans ^{[3
]}

Porter, David L. ^{[1
]}

Xu, Jun

June, Carl H.

Melenhorst, Jan Joseph ^{[1
]}

机构：

[1] Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA USA

[2] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA USA

[3] Novartis Inst Biomed Res, Cambridge, MA USA

[4] Univ Penn, Philadelphia, PA USA

[5] Univ Penn, Ctr Cellular Immunotherapies, Sch Med, Philadelphia, PA USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.57.57

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] T-cell malignancies with anti-CD19 chimeric antigen receptor T-cell therapy
Martin, Lisa J.
Whitmore, James B.
Shen, Rhine R.
Neumann, Frank
BLOOD ADVANCES, 2024, 8 (15) : 4144 - 4148
[2] Gene expression signatures of response to anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in patients with CLL and ALL
Orlando, Elena
Leary, Rebecca
Lacey, Simon F.
Fraietta, Joseph
Bedoya, Felipe
Ambrose, David
Wilcox, Nicholas
Maude, Shannon L.
Frey, Noelle V.
Levine, Bruce L.
Grupp, Stephan A.
Porter, David L.
Young, Regina
Winckler, Wendy
Morrissey, Michael
June, Carl H.
Melenhorst, Jan Joseph
Brogdon, Jennifer
Bitter, Hans
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
[3] Tisagenlecleucel, an approved anti-CD19 chimeric antigen receptor T-cell therapy for the treatment of leukemia
Liu, Y.
Chen, X.
Han, W.
Zhang, Y.
DRUGS OF TODAY, 2017, 53 (11) : 597 - 608
[4] Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta
Simon F. Lacey
Elena J. Orlando
Iulian Pruteanu-Malinici
Mercy Gohil
Stefan Lundh
Alina C. Boesteanu
Yan Wang
Roddy S. O’Connor
Wei-Ting Hwang
Edward Pequignot
David E. Ambrose
Changfeng Zhang
Nicholas Wilcox
Felipe Bedoya
Corin Dorfmeier
Fang Chen
Lifeng Tian
Harit Parakandi
Minnal Gupta
Regina M. Young
F. Brad Johnson
Irina Kulikovskaya
Li Liu
Jun Xu
Sadik H. Kassim
Megan M. Davis
Bruce L. Levine
Noelle V. Frey
Donald L. Siegel
Alexander C. Huang
E. John Wherry
Hans Bitter
Jennifer L. Brogdon
David L. Porter
Carl H. June
J. Joseph Melenhorst
Nature Medicine, 2018, 24 : 563 - 571
[5] Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Fraietta, Joseph A.
Lacey, Simon F.
Orlando, Elena J.
Pruteanu-Malinici, Iulian
Gohil, Mercy
Lundh, Stefan
Boesteanu, Alina C.
Wang, Yan
O'Connor, Roddy S.
Hwang, Wei-Ting
Pequignot, Edward
Ambrose, David E.
Zhang, Changfeng
Wilcox, Nicholas
Bedoya, Felipe
Dorfmeier, Corin
Chen, Fang
Tian, Lifeng
Parakandi, Harit
Gupta, Minnal
Young, Regina M.
Johnson, F. Brad
Kulikovskaya, Irina
Liu, Li
Xu, Jun
Kassim, Sadik H.
Davis, Megan M.
Levine, Bruce L.
Frey, Noelle V.
Siegel, Donald L.
Huang, Alexander C.
Wherry, E. John
Bitter, Hans
Brogdon, Jennifer L.
Porter, David L.
June, Carl H.
Melenhorst, J. Joseph
NATURE MEDICINE, 2018, 24 (05) : 563 - +
[6] Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia
Fraietta, Joseph A.
Lacey, Simon F.
Orlando, Elena
Pruteanu, Julian
Gohil, Mercy
Wang, Yan
Boesteanu, Alina
OConnor, Roddy
Ambrose, David E.
Hwang, Wei-Ting
Wilcox, Nicholas
Bedoya, Felipe
Dorfmeier, Corin
Chen, Fang
Parakandi, Harit
Gupta, Minnal
Pequignot, Edward
Johnson, F. Brad
Kulikovskaya, Irina
Liu, Li
Lundh, Stefan M.
Xu, Jun
Davis, Megan M.
Young, Regina M.
Levine, Bruce L.
Siegel, Don L.
Huang, Alexander
Wherry, E. John
Zhou, Jing
Paczkowski, Patrick
Mackay, Sean
Brogdon, Jennifer
Bitter, Hans
Porter, David L.
June, Carl H.
Melenhorst, J. Joseph
BLOOD, 2017, 130
[7] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
Rapoport, Aaron P.
REVISTA CHILENA DE LITERATURA, 2024, (109): : 1019 - 1020
[8] Anti-CD19 chimeric antigen receptor T-cell therapy for B-cell acute lymphoid leukemia
Rapoport, Aaron P.
HAEMATOLOGICA, 2024, 109 (04) : 1019 - 1020
[9] ZUMA-8: A Phase 1 Study of KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Davids, Matthew S.
Kenderian, Saad S.
Flinn, Ian W.
Hill, Brian T.
Maris, Michael
Ghia, Paolo
Byrne, Michael
Bartlett, Nancy L.
Pagel, John M.
Zheng, Yan
Kanska, Justyna
Zhang, Wangshu
Masouleh, Behzad Kharabi
Granados, Enrique
Ibarz, Javier Pinilla
BLOOD, 2022, 140 : 7454 - 7456
[10] Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia
Bair, Steven M.
Porter, David L.
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S10 - S17

← 1 2 3 4 5 →